Immunotherapy before surgery shows promise for oral cancer
NCT ID NCT03021993
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the drug nivolumab in 17 people with advanced oral cavity cancer before they had surgery. The goal was to see if the drug could shrink tumors before removal. Nivolumab is an immunotherapy that helps the immune system fight cancer. The trial has been completed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL CAVITY SCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States